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INTRODUCTION
- Uveitis  refers  to inflammation of the middle vascular  tunic  of  the  Eye 
called uvea.
- The name uvea is derived from the Latin word "uva" or grape, consists of 
three parts the iris, the ciliary body and the choroid. 
- Uveitis  is  extremely  important  epidemiologically  in  underdeveloped, 
developing  &  developed  societies  alike  accounting  for  a  very  large 
medical & economic burden on population.
- Despite  the  progress  made  since  the  introduction  of  steroid  therapy in 
1950;  large  number  of  patients  eventually  are  blinded  by  the 
consequences  of  recurrent  or  chronic  uveitis;  this  problem  is 
consistently agreed to be the 3rd leading cause of preventable blindness 
in all developed societies.
- If we ever hope to reduce the prevalence of blindness that is secondary to 
uveitis, ophthalmologists in large numbers must embrace a philosophy 
of earlier; more aggressive therapy with a limit to the total amount of 
steroid ultimately used.
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HISTORICAL REVIEW
1500 - Eben's Pappyrus mentioned about congestion of Eyeball
1722 - Charles Saint Yyes described about clinical symptoms like Redness, 
Lacrimation, photophobia, and pain.
1801 - Johann Adam introduced the term Iritis.
1829 - Fredrich Vonammon - inflammation of orbicularis ciliaris
1853 - Von Arlt - gave causes of uveitis - Scrofula 30%, Rheumatism 25%, 
Syphilis 17% & Idiopathic 25.5%
1866 - Von Graefe & Ernest Fuch's described cyclitis.
1869 - Hutchinson initially described sarcordosis as skin disease.
1881 - Von Michael emphasized the importance of Tuberculosis as cause of 
uveitis.
1892 - Nettleship considered a case of Exudative choroiditis due to dental 
infection.
1908 - Toxoplsma Gondii isolated from North African Rodent by Nicollex 
Manceaux
1931 - Kolmer puts forward role of bacterial toxin & allergy as uveitis cause.
1940 - Brucellosis and Sarcoidosis were recognized as clinical entities.
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1946 - Allan `C' wood considered that 79% of Granulomatous uveitis was 
due to Tuberculosis.
1950 - Toxoplasmic  uveitis  became  a  proven  infection  &  thus  parasitic 
infection played a considerable role in the etiology of posterior 
uveitis
1960 - Alan Churchill Woods described in detail about Endogenous uveitis.
1961 - Woods considered Histoplasmosis to be cause of 13% of uveitis.
1990 - The effect of uveitogenic antigens on the eye & the immune response 
peculiar to the ocular structure have become the major subject of 
research.
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CLASSIFICATION OF UVEITIS
A) Anatomical  Classification  by  International  Uveitis  Study  Group 
(IUSG) 
1. Anterior
• Iritis
• Anterior cyclitis
• Iridocyclitis
2. Intermediate
• Posterior Cyclitis
• Hyalitis
• Basal Retinochoroiditis
3. Posterior
• Chorioretinitis
• Retinochoroiditis
• Neurouveitis
• Choroiditis
 Focal
 Multifocal
 Diffuse.
4. Panuveitis
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B) Etiological Classification
Group 1: Idiopathic
1a: With only ocular features
1b: With both ocular and systemic features
Group 2: Infections
2a: With only Ocular features
2b: With both ocular and systemic features
Group 3: Non-infections
3a: With only ocular features
3b: With both ocular & systemic features
C) Clinical Classification
On duration and onset On Activity
♣ Acute ♣ Active
♣ Chronic ♣ Resolved
♣ Recurrent
On Clinical Features On complications 
♣ Granulomatous ♣ Simple
♣ Non Granulomatous ♣ Complicated
On threat to Vision  
♣ Mild
♣ Severe
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ANATOMY OF UVEA 
The  uvea  consists  of  the  iris,  ciliary  body  and  choroid.  Iris  forms  a 
diaphragm perforated by the pupil, the peripheral root of the iris arises from the 
anterior end of the ciliary body, which is attached to the sclera 2mm behind the 
limbus.
IRIS
The  anterior  surface  of  the  iris  is  divided  into  an  inner  1-2mm  wide 
pupillary zone and outer ring called ciliary zone. At the junction of pupillary 
and ciliary zone is a frill called collarette. The anterior surface of the iris bears 
numerous radial furrows, while the posterior surface bears concentric furrows 
of schwalbe.
LAYERS OF THE IRIS
1) Anterior Endothelium: Present only as island at places.
2) Anterior  Limiting  Border  layer:  is  the  anterior  condensed  part  of 
stroma, which contains blood vessels, nerve endings & pigment cells.
3) Stroma:  Major & Minor arterial  circles  are  situated here.  The smooth 
muscle sphincter pupillae is present which is supplied by short ciliary 
nerves.
4) Posterior  Membrane: Layer  of  smooth  muscle  fiber  called  dilator 
pupillae.
5) Posterior Epithelium:  This  consists  of  two layers  of richly pigmented 
cells.
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CILIARY BODY
It extends for 6mm from the root of Iris to the ora serrata. The posterior 
two thirds, the pars plana has a smooth black surface, marked only by faint 
striae- ciliaris, running on the teeth of the ora serrata while the anterior third - 
parsplicata bears about 72 radial ridges, or ciliary processes. It is from these the 
fibres of Zonules take origin.
NERVE SUPPLY: The main supply is via short ciliary nerve.
BLOOD SUPPLY: Long Posterior & Anterior Ciliary arteries
CHOROID
It is the most posterior part of vascular coat of Eye. It is thin, soft, brown 
coat lining the inner surface of the sclera. It is extremely vascular. It is thickest 
at  the  posterior  pole  (about  0.22mm)  &  gradually  thins  anteriorly  (about 
0.1mm). Its inner surface is smooth & firmly attached to the pigmented layer of 
the retina; its outer surface is roughened. It is firmly attached to the sclera in 
the region of the optic nerve and where the posterior ciliary arteries and ciliary 
nerves enter the Eye. It is also tethered to the sclera where the vortex veins 
leave the Eyeball. At the optic nerve the choroid becomes continuous with the 
pia and arachnoid.
LAYERS OF THE CHOROID
1. Suprachoroid lamina of Fusca: This is the layer of choroid in relation to 
sclera. It is 10-34µ in thickness. It contains a delicate meshwork of Elastin 
fibres. These are lined by endothelium and enclose potential lymphatic spaces. 
The spaces become evident, when pathologically distended with fluid, giving 
an appearance of a grill. The layer contains fibrocytes (called chromatophores) 
with short processes and pigment. Pigments are more in the posterior aspect. 
This layer consists the long and short ciliary nerves and vessels.
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2. Layers of Haller and Sattler: These are the layers of blood vessels. The 
layer of Haller contains large vessels whereas in the layer of Sattler vessels are 
medium sized. The stroma in these layers contains collagen and elastic fibres. 
Stellate  pigment  cells  or  chomatophores  are  present.  The  size  of  pigment 
granules in them is same in one individual but differs from race to race. The 
choroid pigments prevent the passage of light through the sclera. They absorb 
the  light  traversing  the  retina,  preventing  internal  reflection  within  vitreous 
body.
3. Layer of Choriocapillaries: The capillaries in this layer are of wide bore. 
Pigment cells are absent. The choroicapillaries end in the ora serrata, whereas 
the  outer  layers  continue  to  the  ciliary  body.  The  capillaries  form  dense 
network at the macula and also show sac like dilatations. The choriocapillaries 
supply the outer part of the retina.
4. Membrane of Bruch (Basal Lamina of Bruch): This is a structure less 
glossy,  homogenous  membrane  about  1.5µ in  thickness  and  is  also  called 
lamina  vitrea.  This  layer  consists  of  two  sheaths.  The  function  of  this 
membrane is not well defined. Probably it helps in the passage of nutrients to 
retina and provides a smooth surface for the precise orientation of the RPE and 
receptors.
NERVE SUPPLY: The vessels of the suprachoroid and stroma show a striking 
dense parasympathetic and sympathetic innervations. Sympathetic Adrenergic 
fibers,  which  arise  from cervical  sympathetic  chain,  have  a  vasoconstrictor 
action.  The parasympathetic  innervations  of  the  choroid are  from the facial 
nerve  and  pterygopalatine  ganglion  and  from  oculomotor  nerve  via  ciliary 
ganglion  and  short  ciliary  nerves.  They  serve  as  vasodilator  role  perhaps 
adjusting  blood  flow in  response  to  reduction  in  arterial  blood  pressure  or 
protecting the retina from thermal damage associated with light exposure.
9
BLOOD SUPPLY:  The short posterior ciliary arteries supply the posterior 
choroid upto the equator and a variable area anterior to it. The temporal long 
posterior ciliary artery supplies a wedge shaped sector of the choroid starting 
from  point  it  enters  the  choroid  posterior  to  the  equator  and  extending 
forwards. The anterior part of the choroid is otherwise supplied by recurrent 
ciliary arteries, which arise in the ciliary body from circulus iridis major and 
from  the  long  posterior  and  anterior  ciliary  arteries  before  they  join  the 
muscular circle.
ANATOMICAL  AND  FUNCTIONAL  VASCULAR  UNITS  OF  THE 
CHOROID
Hayreh  (1974,  1975,  1990)  and  Torazynstri  &  Tso  (1976)  showed  in 
human studies that each terminal arteriole appeared to supply an independent 
segment or lobule of choriocapillaries compromising a central feeding arteriole, 
capillary bed and a series of peripheral draining venules.
CHOROIDAL  ANATOMY  &  CIRCULATION  IN  RELEVANCE  TO 
CHOROIDITIS
The  choroid  has  a  blood  flow  that  is  comparable  only  to  the  kidney. 
Therefore systemic influences can be assumed to rapidly affect this portion of 
the eye. Indeed the relative large blood flow and its anatomy would act as a sort 
of  trap  for  many  blood  borne  problems  most  notably  fungal  disorders. 
Therefore most fungal lesions begin as choroiditis. The choroid has a capacity 
to  function  as  a  repository  for  immunoreactive  cells  in  the  extreme stages, 
taking  on  the  anatomic  structure  of  a  lymph node  (lymphoid  hyperplasia). 
Therefore this organ can be center for profound immune responses. The high 
concentration of mast cells in the choroid may be one of the mechanism by 
which immuno reactive cells in the choroid could spread to other parts of the 
eye.
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UVEITIS PATHOGENESIS AND 
RELATED IMMUNOLOGY
One of the oldest & major hypothesis is the concept of direct bacterial 
invasion.  Another  hypothesis  for  recurrent  ocular  inflammation  assumes  a 
structural alteration within the eye resulting from a previous inflammation that 
predisposes the eye to recurrent inflammatory episodes. Some acknowledged 
facts in pathogenesis are:
FOCAL INFECTION:  Any focal sepsis is a predisposing factor for uveitis 
since most of the ocular inflammation is infective in nature. Among the foci of 
infection the teeth is considered the most prolific source. The others being the 
tonsils, para nasal sinuses, respiratory tract, skin, alimentary tract, uterus and 
the urinary tract.
PROSTAGLANDINS  AS  AETIOLOGIC  UNIT:  Prostaglandin  is  a 
chemical mediator involved in the pathogenesis of uveitis. Prostaglandin causes 
dramatic increase in protein content in aqueous humor and vitreous. 
VITREOUS ANTIGEN DEPOT: Once Antigen gains access to the vitreous 
body, it tends to persist. One reason for this is that hyaluronic acids form stable 
complexes with antigens. This  depot type of situation tends to enhance and 
prolong  immune  response  to  trapped  antigen.  Since  Hyalocytes  have 
macrophagic character, they may promote a persistent tendency to recurrence 
of uveitis by processing antigen and modulating the immune responses.
UVEA AS A  NODE: When the antigen is introduced at a distance site or is 
injected directly into the circulation, antibody production begins inside the eye. 
11
The specific antibody produced takes up residence within the uvea and remains 
there for long period. Here the new antigen is needed to stimulate them for the 
renewal of the antibody response. 
IMMEDIATE  HYPERSENSITIVITY  (ANAPHYLAXIS):  This  results 
from  contact  of  the  uveal  tissue  to  some  foreign  protein  namely  bacterial 
protein, where an immediate antigen Antibody reaction occurs.
DELAYED  HYPERSENSITIVITY  (BACTERIAL  ALLERGY):  The 
tissues are sensitized by contact with living or dead organism so that further 
contact  with  same  antigen  causes  severe  cellular  damage,  which  develops 
slowly causing an inflammatory, and necrotic tissue reaction.
IMMUNE CHARACTERISTICS OF THE EYE: For  years  the  Eye  was 
considered to be a "Privileged Immune Site" - implication of this term was that 
the immune system somehow ignored or was tolerant of the antigens in the 
Eye. As with Brain, placenta, testes, Eyes have no direct lymphatic drainage 
although in mice submandibular nodes do collect antigen from the eye. 
FOUR MECHANISMS BY WHICH EYE PROTECTS ITSELF FROM 
UNWANTED NUISANCES
1. Blood ocular Barrier
2. Presence of soluble/membrane bound inhibitors that block function of an 
organism.
3. Kill  an  invading  organism  /  cell  that  may  be  inducing  an  unwanted 
inflammation (by speeding up Apoptosis)
4. Tolerance is induced inside the eye.
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IMMUNE RESPONSE TO INVADING VIRUSES & PARASITES
 Certain viruses have a particular propensity for retinal tissue with Herpes 
family infections particularly CMV being of ever increasing concern.
 Cellular immune mechanism appears to play a crucial role in eliminating 
the  invading  virus.  Any  damage  to  this  system  could  lead  to  grave 
consequences. This is the case with infection due to HIV: have secondary 
repercussions in the body's attempt to clear other viral infections such as 
CMV.
 The classical described response to parasitic infections is an eosinophilia. 
The release of basic protein and other toxic produces from the eosinophil is 
thought to kill the organism. Eosinophilia is characteristic for some forms 
of  ocular  parasitic  infections  such  as  toxocariasis.  However  for  other 
infections  such  as  toxoplasmosis  and  onchocerciasis,  T  cells  seen  to 
predominate  in  the  Eye  &  deficient  T  cell  functioning  lead  to  serious 
consequences --> systemic and ocular toxoplasmic infection seen in patients 
with AIDS.
 Immunosuppressive factors appear to be elaborated by the parasite leading 
to a downgrading of macrophage & T cell activity around it.
 Certain  parasites  cloak  themselves  in  non-antigenic  proteins  avoiding 
immune attack eg. toxoplasma cyst.
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CLINICAL FEATURES OF POSTERIOR UVEITIS 
SYMPTOMS
A  careful  and  detailed  medical  history  is  one  of  the  keys  to  correct 
diagnosis in the patient with uveitis. Floaters and decreased vision are the two 
most common complaints of patients with inflammation of the vitreous, retina 
and choroid. Most patients describe floaters as multiple small or medium sized 
spots that  moves as their  eye moves.  Other patients  complain of blurred or 
decreased vision.  Infact,  when visual  acuity is  severely diminished,  patients 
may be unable to visualize the floaters and these patients may only complain of 
floaters as vision starts to improve after therapy. A change in the pattern of 
floaters or visual impairment often signals a change in the underlying ocular 
disease.  A  patient  with  a  peripheral  inflammatory  lesion  will  complain  of 
floaters  and may have only minimal  blurring of  vision.  On the other  hand, 
active choroiditis involving fovea will usually cause loss of central vision. 
SIGNS
The ocular examination of patients with uveitis is important not only to 
diagnose  the  disease  appropriately  but  also  to  determine  the  appropriate 
therapy.
SLIT LAMP BIOMICROSCOPY
1. Ciliary  Injection:  results  from  engorgement  of  the  radial  episcleral 
vessels and is seen as violaceous hue around the limbus.
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2. Keratic Precipiatates:  They are small aggregates of inflammatory cells 
that accumulate on the endothelial surface of the cornea.
3. Flare:   this  is  turbidity  of  the  ocular  media  (aqueous/vitreous)  due  to 
transudation of proteins across the inflamed blood vessels. It is a sign of 
disruption of the blood ocular barrier.
Grading of Anterior Chamber Flare by Hogan et al.
Flare 
Grade
Description
0
1+
2+
3+
4+
Complete Absence
Very Slight (Faint Flare)
Iris & Lens details clear (Moderate Flare)
Iris & Lens details hazy (Marked Flare)
Fixed Coagulated aqueous with considerable fibrin (Intense Flare)
4. Cells: Depending on the nature and severity of inflammation, various cells 
may migrate across the iris and ciliary vasculature into the aqueous and 
vitreous. The vitreous is rarely a source of inflammatory cells except in 
certain situations.
Grading of Anterior Chamber Cells by Nussenblatt et. al.
Grade No. Of Cells
0
1+
2+
3+
4+
Hypopyon
0
< 10 Cells
11-20 Cells
21-50 Cells
> 50 Cells
15
5. Grading of Vitreous Haze:  Vitreous haze is a better indicator of active 
inflammation than vitreous cells because it combines the optical effect 
of cellular infiltration and protein leakage. Grading scale is based on the 
view of the optic disc and posterior retina with the use of the indirect 
ophthalmoscope and a 20D lens. It is important to mentally correct for 
lens opacities, anterior segment inflammation and corneal disease. The 
use of photographic standards makes this system more reproducible.
Grade Description
0 Nerve Fiber Striations well defined
1+ Better  definition  of  optic  Nerve  Head  and  Retinal  blood 
vessels
2+ Better visualization of retinal blood vessels
3+ Optic Nerve Head Visible but its borders blurred
4+ Optic Nerve Head obscured
6. Grading of Vitreous Cells: The vitreous is larger cells may be localized 
to only a part of vitreous. Therefore the quantification may depend on 
how the eye is examined. The Grading of vitreous cells described by 
Kimura & Colleagues uses the Hruby lens to view the cells in retro 
illumination. The cells appear as black dots.
Grade Cells in Retroilluminated Field Description
0+
Trace
1+
2+
3+
4+
0-1
2-20
21-50
51-100
101-250
>251
Clear
Few Opacities
Scattered Opacities
Moderate Opacities
Many Opacities
Dense Opacities
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The cells appear as black dots and it may be difficult to differentiate uveal 
debris  from active  inflammatory  cells.  Debris  is  often  pigmented  and form 
clumps that are longer than individual cells.
7. Retina & Choroid
Examination  is  best  done  with  a  combination  of  indirect 
ophthalmoscope, Hruby lens, +90D lens and a mirrored contact lens. 
i) Cystoid Macular Edema:   is a common retinal finding in patients with 
uveitis.  Although  Fluorescein  angiography  can  more  definitively 
document the presence of macular edema, clinical examination with the 
Hruby lens is easier, cost effective, determines the extend of macular 
thickening associated with Edema and can be performed on each visit. 
In the presence of vitreous haze it is best observed by viewing with light 
directed slightly to one side of the fovea.
ii) Retinal  Vascular  alterations:   Vascular  sheathing  of  arteries 
(periarteritis)  and veins (periphlebitis)  by infiltration  of  inflammatory 
cells around the vessels is easily seen in posterior pole. Periphlebitis is 
commoner than periarteritis,  both being characterized by fluffy white 
haziness surrounding the blood column. Vessel narrowing, obliteration, 
retinal hemorrhages and cotton woolspots often accompany. Peripheral 
vascular sheathing and narrowing is subtler and is best evaluated with 
the indirect ophthalmoscope.
iii) Choroidal Lesions:  When deep or isolated to choroid appear as grayish - 
yellow  demarcated  masses.  One  or  more  choroidal  nodules  may  be 
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present  and  can  vary  in  size  from  50  µm  to  500  µm  in  diameter. 
Atrophic chorioretinal lesions with surrounding hyper pigmentation are 
a  striking  sign  of  inflammatory  disease  in  the  patients  with  uveitis. 
Although  the  appearance  of  inflammatory  lesions  of  the  retina  and 
choroid can vary greatly, some lesions have a characteristic presentation 
and can help in diagnosis. Eg. Dalen Fuchs nodules tend to be small, 
discrete,  deep,  yellow  white  lesions  that  may  be  associated  with 
hyperpigmentation.
8. Optic Nerve
Uveitis  may affect  the  optic  nerve  in  several  ways.  Disc  hyperemia, 
papillitis or papilledema may be seen. So,  in determining the cause of 
visual  loss  in  eyes,  optic  nerve  head  should  not  be  overlooked. 
Prominent  disc  hyperemia  is  frequently  noted  in  VKH  syndrome. 
Neovascularisation,  glaucomatous  damage  or  optic  Atrophy  may 
develop in  the  optic  disc.  Inflammatory  disease  like  sarcoidosis  may 
directly involve the nerve.
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INVESTIGATIONS
Royal College Guidelines:   Ordering large number of tests in the hope that 
one may turn out to be positive should be actively discouraged. Also if one 
does many investigations on a single patient, there is the chance that something 
will turn out to be abnormal but it may not have relevance to the etiology of 
uveitis.
Reasons to Investigate Posterior Uveitis are
1) Come to a specific diagnosis.
2) Confirm a clinical diagnosis.
3) Commence antimetabolite / Immuno suppressive therapy.
4) Identify complications.
5) To explain cause of poor vision
6) Rule out Masquerade Syndromes/infections
1) Haematological Investigations :  Estimation of Hb., TLC, DLC, ESR or 
routine urine analysis are nonspecific and of no help in the diagnosis, 
hence are not advocated. However, they are important when the patient 
is  to  be  started  on  anti  metabolites.  In  these  patients,  baseline  and 
repeated values are necessary in detecting bone marrow depression and 
dose adjustment. An important hematological investigation is estimation 
of CD4/CD8 lymphocyte ratio in patients with suspected HIV infection. 
In  patients  with  AIDS this  is  the  single  best  predictor  of  imminent 
opportunistic  infection.  The normal  ratio  is  usually  2.0  and in  AIDS 
patient becomes reversed with value of 0.5 - 1.0.
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Hematological Investigations - When?
• Commencing antimetabolite/Immunosuppressive therapy.
• Suspicion of Parasitic Infestation
• Suspicion of Leukemia
2) Immunological Investigation(s)
Some important serological investigations are:
a) Rheumatoid Factor:  This is detected by immuno turbimetry and has no 
role in the diagnosis of uveitic entities. However it forms the basis of 
dividing arthropathies into seropositive and seronegative.
b) Anti nuclear Antibodies: ANA detection is the most sensitive laboratory 
test for SLE and is present in 99% of these cases.
c) Anti-DNA  Antibodies: Antibodies  against  double  standard  DNA  are 
found in 40-80% of cases of SLE and only rarely in other connective 
tissue disorders. 
d) Anti-Neutrophil  Cytoplasmic  Antibodies  (ANCA):  ANCA  are  the 
group of autoantibodies that occur in a large majority of patients with 
systemic small vessel vasculitis. 
e) Angiotensin Converting Enzyme (ACE): Serum ACE levels are elevated 
in 85% of patients  with active pulmonary disease due to sarcoidosis. 
S.ACE levels is considered to be elevated if the value is above 35 IU/ml 
in adults and 50 IU/ml in those below 10 years.
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f) Serum Globulin:   75% of patients with sarcoidosis have elevated serum 
globulin levels. 
g) Serum Lyzozyme: In sarcoidosis, serum levels of Lysozyme have been 
found to be elevated in 70% of cases irrespective of whether the disease 
is active/inactive.
h) Serological tests for infections agents 
i) Toxoplasmosis (IgG)
No previous infection : < 1:16
Prevalent in general population : 1:16 - 1:256
Suggests recent infection : > 1 : 256
Suggests active infection : > 1: 1024
ii) Toxoplasmosis (IgM)
In children : any titer is significant
In adults : > 1:64 indicates active infection.
iii) Herpies Simpler IgM & IgG <1:5 & <1:10 (Negative)
iv) Varicella Zoster (IgG/IgM) <1:10 (Negative)
3) Radiological Investigations 
A simple chest X-ray should be done in all cases of uveitis to rule out 
sarcoidosis. X-ray done at the onset of eye inflammation has greatest likelihood 
of  detecting  abnormality  as  it  may  become  normal  despite  persistent  eye 
inflammation. It is important to establish the diagnosis of sarcoidosis, since it 
has prognostic and therapeutic significance.
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 Radiological Investigations - When?
• Skull : Congenital toxoplasmosis
• Chest : Sarcoidosis / tuberculosis/malignancy.
• Sacroiliac & Spinal : Ankylosing spondylitis
• Gallium Scan : Sarcoidosis
 
Gallium scan may be abnormal in some cases of sarcoidosis. However, 
its cost, lack of theraupetic implications and non specificity forbids its routine 
use. Skull X-ray (lateral) to evaluate for calcification in suspected congenital 
toxoplasmosis  case  should  not  be  overlooked.  Sinus  radiography  has  also 
traditionally been done in cases of uveitis, however, its value in diagnosis or 
prognosis is not clear.
4) HLA Typing 
HLA  antigens  are  now  considered  to  be  the  genetic  markers  for 
susceptibility.  The classical example for this is  association of acute anterior 
uveitis  in HLA-B27 positive individuals.  The other accepted associations are 
shown below
 HLA Typing
• Behcet's disease : HLA-B-5
• Birdshot retinochoroidopathy : HLA-A29
• Sympathetic Ophthalmia : HLA-A11
• Vogt-Koyanagi-Harada Syndrome : MT-3/HLA BW 22J
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HLA typing is an expensive test and should be ordered only for patients 
in whom it would make a therapeutic or prognostic difference. It is reserved for 
patients  with  an  acute  onset,  anterior,  unilateral  uveitis.  In  some  cases  of 
Behcet's,  the  diagnosis  may be a  problem and confirming it  with  the  HLA 
typing may help the surgeon to put the patient on immunosuppressives rather 
than steroids.
5.     Skin Test
The  basis  for  all  skin  tests  is delayed hypersensitivity reaction of 
type IV. Many skin tests are available that can be used for the diagnosis of 
different  etiologies  of  uveitis.  Its  main  use  has  been  in  the  diagnosis  of 
tuberculosis and histoplasmosis. Sometimes it has also been used to indicate 
anergy in cases of sarcoidosis.
Dermatological Tests
• Tuberculosis : Mantoux Test
• Histoplasmosis : Histoplasmin test
• Sarcoidosis : Kveim test
• Anergy : Sarcoidosis/leprosy
6) Fluorescein Angiography
It is an important test in evaluating cases of uveitis. FFA is very useful 
in  inflammatory  disease  due  to  its  ability  to  visualize  retinal  vessels  and 
delineate their walls. The inflammation of retinal vessels alters the endothelial 
tight junctions due to which fluorescein leaks from the vessels. Thus, vasculitis 
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can be diagnosed well before it is seen clinically. FFA also helps in assessing 
the leakage of dye from retinal capillaries in the macula and optic nerve in 
CME  &  papilliltis  respectively;  presence  of  retinal  vascular  occlusion  and 
retinal  and  choroidal  neovascularisation  can  be  easily  seen  with  FFA.  It  is 
helpful  in  differentiating  the  active  lesion  from  healed  one  in  retinal  and 
choroidal  diseases.  In  active  stage,  the  margins  of  the  lesion  show diffuse 
staining and blurring. Healed stage shows hyperfluorescence with well-defined 
margins.
Posterior uveitis entities in which FFA is indicated are
1) Serpiginous  choroidopathy  or  Geographic  Helicoid  Peripapillary 
Choroiditis (GHPPC)
2) Sarcoidosis
3) Acute Posterior Multifocal Placoid Pigment Epitheliopathy (APMPPE)
4) Multiple Evanescent White Dot Syndrome (MEWDS)
5) Sympathetic Ophthalmia
6) Vogt Koyanagi Harada Syndrome
7) Retinal Vasculitis
8) Bird Shot retinochoroidopathy
9) Behcet's disease
10) Inflammatory Choroidal neovascular membrane (CNVM)
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7) Indocyanine Green Angiography (ICG)
The major drawback of FFA is its inability to image the choroid and 
detect  inflammatory  conditions  affecting  the  choroid  and  choriocapilliaries. 
Flower and Flochheimer introduced this technique, which images the choroid 
and its associated conditions, in 1970. It uses a tricarbocyanine dye which is 
98% protein  bound and operates in infrared range. The dye absorbs light at 
790 nm and emits at 830 nm. It leaks through fenestrated choriocapillaries thus 
allowing  visualization  of  choroidal  circulation  through  RPE.  Choroidal 
inflammatory lesions are mostly seen as areas of Hypofluorescence in ICG. 
Various inflammatory conditions where ICGA is advised are
i) Multifocal choroiditis
ii) APMPPE
iii) MEWDS
iv) GHPPC
v) Birdshot Chorioretinopathy
8) Optical Coherence Tomography (OCT)
It  is  a  relatively  newer  method  of  high  resolutional  cross  sectional 
imaging in retina. It is based on the principle of low coherence interferometry 
in  near  infrared  range  to  achieve  high  resolution  of  10-14mm;  It  directly 
measure the thickness of retina. In uveitis it is particularly useful in diagnosis 
and  follow  up  of  cystoid  macular  Edema,  macular  hole  and  epiretinal 
membranes.
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9) Polymerase Chain Reaction (PCR)
It  has  rapidly  become  established  as  one  of  the  most  widely  used 
techniques of molecular biology. It is rapid, inexpensive and simple means of 
producing  microgram  amounts  of  DNA  from  minute  quantites  of  source 
material.
Pathogens Detected by PCR are
CMV, HSV, VZV, EBV, HPV, Hepatitis A,B,C, HIV type I & II, 
Rubella   Rickettsia  rickettsii, Borrelia  Burgdorferi,  Treponema 
Pallidum  Mycobacterium  Tuberculosis,  Neisseria  meningitis, 
Hemophilis  influenza,  Streptococci,  Staphylococci  Toxoplasma 
Gondii, Pneumocystis Carnii, Acanthamoeba Species.
It is especially useful in Endophthalmitis, atypical toxoplasmosis, viral 
and tuberculous retinitis.
10) B Scan Ultrasonography
Safe, non-invasive, rapid imaging modality which uses frequencies in 
the  range of  7.5  -  1.5  MHz;  for  evaluation of  posterior  globe and orbit.  It 
evaluates  the  posterior  segment  in  conditions  with  media  opacities  such  as 
complicated  cataract,  vitreous  hemorrhage,  dense  vitritis,  corneal  opacity, 
mosed pupil. It is also helpful in diagnosing sympathetic ophthalmia & VKH 
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syndrome  by  revealing  associated  retinochoroidal  thickening  and  exudative 
retinal detachment.
11) Diagnostic Surgery
AC Paracentesis
 Simple and safe procedure, which can be performed by an experienced 
ophthalmologist.  It  can  be  done  at  the  slit  lamp or  under  a  microscope  in 
operation  theatre.  About  0.1-0.3  ml  Aqueous  fluid  is  collected  with  a  27G 
needle attached to a tuberculin syringe.
Vitreous Tap & Diagnostic Vitrectomy
Vitreous fluid analysis is considered in some sight threatening uveitis in 
diagnostic Dilemmas and Masquerade Syndromes. 
Retinal & Chorioretinal Biopsy 
In diagnostic dilemmas where inflammation is localised to Retina and 
RPE tissue biopsy can be performed in order to understand the disease and 
make  a  definitive  diagnosis.  Biopsy  site  should  be  at  border  of  active 
chorioretinal disease and normal retina.
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NON SPECIFIC MANAGEMENT  IN POSTERIOR UVEITIS
The objective of treatment in a patient is to preserve macular acuity, to 
preserve visual fields, provide symptomatic relief, to prevent complications and 
managing any systemic associations if any.
Treatment  Protocol in Posterior Uveitis
1) Corticosteroids
The mainstays of anti-inflammatory therapy for most types of uveitis 
and  effectively  suppress  the  inflammatory  response  regardless  of  cause. 
Though these drugs are effective in ameliorating the inflammation in a large 
majority of patients they have the potential for producing significant ocular and 
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systemic  morbidity.  Hence  caution  is  recommended  in  their  use.  It  is 
mandatory  to  elicit  specific  patient  history  for  diseases  such  as  diabetes 
mellitus,  hypertension,  peptic  ulceration,  osteoporosis  etc.  that  may  get 
aggravated  by  prescribing  systemic  corticosteroids.  The  risk,  nature  and 
severity of adverse effects depend both on the dose and duration of treatment.
 Cortiosteroids can be administered by 3 routes:
1) Topical
2) Periocular
3) Systemic (oral & parental)
1) Topical costicosteroids
These are absorbed quite well through the cornea and form the mainstay 
of therapy of anterior uveitis. They do not reach the posterior segment to the 
desired extend and so have no beneficial effect in posterior uveitis.
2) Periocular Injection
With this modality of treatment maximum concentration in uveal tissue is 
achieved with minimal systemic side effects. An experimental study has shown 
that both methyl prednisolone and triamcinolone acetonide penetrate well into 
the vitreous cavity and retina following posterior sub-Tenon’s injection. The 
effect of short-acting depot steroids lasts for a few hours to one day while the 
effect of long-acting depot steroids lasts for two to three weeks. A list of the 
commonly used injectable corticosteroid preparations is given in Table.
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COMMONLY USED INJECTABLE 
CORTICOSTERIOD PREPARATIONS
Short - acting: (Few hours to one day)
Hydrocortisone acetate (25mg/ml)
Btamethasone (4mg/ml)
Dexamethasone (4mg /ml)
Long-acting (2 to 3 weeks)
Methylprednisolone acetate (40 mg/ml)
Triamcinolone acetonide (20 mg/ml) or 40 mg/ml)
Subconjunctival Injection
It is useful in cases of anterior uveitis, which do not respond to topical 
therapy.  Subconjunctival  injections  are,  however,  ineffective  in  posterior 
uveitis as intraocular penetration is poor.
Posterior sub-Tenon’s Injections
Posterior  sub-Tenon’s  injection is  recommended in  intermediate  uveitis 
and in posterior uveitis along with systemic steroids and in panuveitis along 
with systemic and topical steroids.
Technique: The best site for injection is the upper temporal quadrant. 
The upper eyelid is elevated and the patient is instructed to look down and in. 
One millilitre of the drug is taken in a 2ml syringe with a 27 gauge, 5/8, inch 
disposable needle. With the bevel towards the globe, the needle is introduced 
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into the superior bulbar conjunctiva and moved from side to side and injected 
into the posterior sub-Tenon’s space.
Retrobulbar Injection
This is seldom preferred because of the high degree of risk involved in the 
technique and the poor intraocular penetration of the drug.
     Complications  related  to  the  effect  of  depot  preparation  of  periocular 
corticosteriods include:
• Systemic absorption
• Increased intraocular pressure
• Scarring between conjunctiva and globe
• Posterior subcapsular cataract
• Hypersensitivity tissue reaction
• Subdermal fat atrophy
• Ptosis and extraocular muscle paresis
• Potentiation of infection
• Worsening of infectious uveitis
Systemic Steriods
Systemic  steroid  therapy  is  used  predominantly  in  posterior  segment 
involvement. It is also used in cases of anterior or intermediate uveitis, which 
have not responded to topical therapy.
Oral  corticosteroids  have  several  potential  hazards.  A  definite  plan  of 
therapy must be made before their use.[The common steroid preparations are 
listed in Table on next page. 
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Generic Name Route
Prednisone Oral
Prednisolone Oral
Dexamethasone Oral
Betamethasone Oral
Methylprednisolone IM or IV
Cortisone IV
General  guidelines  for  oral  corticosteriod  therapy  are  given  below: 
(Modified from Gordon DM)
• Use enough,  soon enough,  often enough and long enough to  secure  the 
desired results.
• Start with a high dose and taper according to the clinical response. An oral 
steroid is started with the maximum dosage (1mg/kg of body wt.) and when 
the desired effect is achieved, is given every alternate day.
• If  therapy  prolongs  for  over  two  weeks,  never  stop  abruptly  at  a  high 
dosage. Taper it slowly. If therapy is to be discontinued, an attempt should 
be made to control the disease with periocular injection.
• Suppress  inflammation  till  the  pathogenic  effect  ends.  Determine  the 
minimal maintenance dose by a process of trial and error. Make an effort to 
reduce  the  dosage  if  there  is  no  sign  of  relapse.  Increase  the  dosage 
immediately in case of recurrence.
• The dosage of steroid should not be tapered with a predetermined plan but 
in accordance to the response of the disease.
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Complications
• Cushingoid features
• Peptic ulceration
• Aseptic necrosis of head of femur
• Osteoporosis
• Steroid - induced diabetes
• Mental changes
• Electrolyte imbalance
• Reactivation of infections
• Cataract
• Increase  in  the  severity  of  pre-existing  disease  such  as  diabetes, 
hypertension.
• Limitation of growth in children.
• Myopathy
Contraindications
Absolute
• Pregnancy
• Peptic ulcer
• Osteoporosis especially during menopause
• Active infection
Relative
• Diabetes mellitus
• Hypertension
• Cardiovascular disease
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Immunosuppressive Agents
Immunosuppressive  agents  are  now  the  first  choice  of  therapy  for 
corticosteriod - resistant cases of uveitis and in cases where corticosteroids are 
contraindicated.
The side effects and potential complications of these agents are many and 
at times fatal. These are therefore reserved as the second line of treatment in 
many cases, the first being corticosteriods.
An immunosuppressive agent should be used with caution. A generalized 
guideline for the use of immunosuppressive drugs is given below.
Immunosuppressive agents are used only when:
• Uveitis is vision - threatening
• Reversibility of the disease process is possible.
• An objective evaluation of the process of disease is possible
• No response to an adequate regimen of corticosteriods is found.
• Systemic corticosteriods are contraindicated.
• Active infection is absent
• Hematological contraindication is absent.
•  The patient understands the needs for a periodic follow-up by the 
ophthalmologist and the internist.
• Informed consent is obtained.
In 1980, the International Uveitis Study Group (IUSG) recommended a 
guideline for the use of immunosuppressive agents, which is given in Table in 
next page.
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GUIDELINE FOR USE OF IMMUNOSUPPRESSIVE AGENTS 
IN UVEITIC DISEASE
Absolute : Behcet’s disease, sympathetic ophthalmia.
Relative : All cases unresponsive to maximum steroid therapy
Questionable : Eales’  disease,  Retinal  vasculitis,  serpiginous 
choroidopathy
Contraindicated : Focal  chorioretinitis,  herpetic  disease,  toxoplasmosis, 
cytomegalovirus, and fungal infection.
Immunosuppressive Agents: Dosage and Reactions
Drug Dosage Major Side Effects
Cyclophosphamide 100 to 150 
mg/day in 
adults 
- Haemorrhagic cystitis
- Bone marrow suppression
- Secondary malignancies
Azathioprine 2 mg/kg of 
body weight
- Bone marrow suppression
- Secondary infection
- Gastrointestinal upsets
- Hepatotoxicity
Methotrexate 7.5 to 25 mg/ 
week
- Hepatotoxicity
- Bone marrow suppression
- Secondary infection 
- Diarrhoea
Cyclosporin A 5mg /kg per 
day of body 
weight
- Nephrotoxicity (75% cases)
- Hypertension (25% casaes)
- Gastrointestinal upset
Chlorambucil 2mg/day 
orally 
- Hepatotoxicity
- Bone marrow suppression
- Gonadal dysfunction
- Secondary malignancies
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COMMON ETIOLOGIES OF POSTERIOR UVEITIS AND 
THEIR SPECIFIC MANAGEMENT
Common Etiologies of Posterior Uveitis
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Without Systemic Association With Systemic Association
Idiopathic
Serpiginous choriodopathy
Senile Vitritis
APMPPE
MEWDS
Post Surgical
Bird shot retino choroidopathy
POHS
Frosted branch angitis
Idiopathic Uveal Effusion 
Syndrome
Posterior  scleritis
Toxoplasmosis
Toxocariasis
Tuberculosis
CMV retinitis
AIDS Related retinopathy
Collagen vascular disease
Behcet's disease
Vogt Koyangi Harada Syndrome
Syphilis
Sarcoidosis
Cysticercosis
Acute retinal Necrosis
Sympathetic Ophthalmia
Intraocular lymphoma
Pneumocystis Choroidopathy
COMMON INFECTIOUS ETIOLOGIES OF POSTERIOR 
UVEITIS
A) PARASITIC
(1) TOXOPLASMOSIS
Is the most common cause of infections retinochoroiditis in humans. It is 
caused by toxoplasmosis Gondii, an obligate intracellular protozoan parasite. 
Cat is the only definitive host. Human is the intermediate host. Toxoplasma 
Gondii exists in 3 forms.
i) Oocyst: Soil form (10  -12 µm)
ii) Tachyzoite : Active infections form  (4 -8 µm)
iii) Tissue Cyst/Bradyzoite : Latent form (10  -12 µm)
Mode of Transmission to humans
1) Ingestion of Oocysts, which are shed in cat faeces and deposited in sand 
and soil around homes.
2) Ingestion  of  toxoplasma  bradyzoites,  the  encysted  form  of  parasite  in 
undercooked meat (pork, beef, mutton & chicken)
3) Blood transfusion / organ transplantation
4) Direct innoculation of the tachyzoites, the proliferative form by accidental 
skin penetration with infected needles.
5) Transplacental transmission of tachyzoites
6) Ingestion of tachyzoites contaminated milk. 
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The diagnosis of Ocular toxoplasmosis is made by the following:
i) Observation of characteristics fundus lesion
ii) Detection  of  the  presence  of  antitoxoplasma antibodies  in  the  patient's 
serum
iii) Reasonable  exclusion  of  other  infectious  diseases  that  might  cause 
necrotizing lesions of the fundus principally syphilis, CMV, Fungus.
Clinical Features
Typical Manifestations
1) Focus of retinitis surrounded by fuzzy retinal Edema.
2) Pigmented Atrophic Retinochoroiditis scar adjacent to lesion or elsewhere.
3) Vitreous cells and exudates
4) Hyperemia of optic nerve head
5) Cells & flare in Anterior chamber
6) Patients with recurrent diseases - posterior synechiae, secondary cataract 
& Glaucoma.
Atypical manifestations
i) Juxtrapapillary Retinitis
ii) Retrobulbar neuritis
iii) Rhegmatogenous Retinal Detachment
iv) Pars Planitis
v) Outer Retinitis
vi) Serous macular detachment
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 Although ocular toxoplasmosis has been considered to be a manifestation of 
congenital infection in most cases, reports of post -nately acquired ocular 
toxoplasmosis are increasing which show frequence recurrences. 
Investigations
1) ELISA  (Serum  &  Aqueous)  -  Antitoxoplasmosis  IgG  &  IgM  - 
Toxoplasma  dye  test  of  sabin  feldman,  the  hemaggluttination  lest, 
indirect  immunofluorescent  antibody  test  all  provide  approximately 
same  information,  however  ELISA  may  offer  more  sensitivity  & 
specificity. Any titer of  serum antibodies is significant if the patient has 
a  fundus  lesion  that  is  compatible  with  ocular  toxoplasmosis.  Titers 
higher in aqueous humor that in serum are more significant.
2) PCR of Aqueous aspirate
3) CT/MRI  Brain  in  cases  of  Toxoplasmic  encephalitis  especially  in 
immunosuppressed patients.
Treatment 
The decision to treat generally would be based on the following criteria:-
i) A lesion within the temporal arcade
ii) A lesion abutting the optic nerve or threatening a large retinal vessel
iii) A lesion that has induced a large degree of haemorrhage
iv) A lesion that has induced enough of vitreal inflammatory response so 
that vision has dropped below 20/40 in a previously 20/20 eye or at least 
has sustained a two line drop from  the visual acuity before the acute 
infection
Drugs 
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1st choice: Sulphadiazine + pyrimethamine + Folinic Acid
Loading 
dose
Following dose Duration
1) Sulphadiazine 4 gm 1  gm  daily  (in  4 
divided dose)
6 Weeks
2) Pyrimethamine 150 mg 25 mg daily 6 weeks
3) Folinic Acid 5 mg 5 mg daily 6 weeks
S/E  :  Sulpha  Compounds:  Skin  rash,  Crystalluria,  Kidney  Stones,  Stevens 
Johnson Syndrome.
2st choice: Cindamycin + Pyrimethamine + Folinic Acid
Loading 
dose
Following dose Duration
1) Clindamycin 600 mg 300  mg  (in  3  divided 
dose)
6 Weeks
2) Pyrimethamine 150 mg 25 mg (daily) 6 weeks
3) Folinic Acid 5 mg 5 mg 6 weeks
S/E : Clindamycin: Pseudomembranous Colitis
Role of Cortiosteroids: They should be judiciously added to the regimen if the 
lesion is in the posterior pole or threatening the optic nerve head. Generally 
20-40  mg/day  in  adult  patient  beginning  12-24  hrs  after  initiation  of  the 
specific antimicrobial therapy and try to taper in such a way that it is stopped 
before antitoxoplasma therapy is discontinued.
 Periocular Corticosteroids are not to be used.
(2) TOXOCARIASIS 
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Is the zoonotic disease caused by infestation of humans by the second 
stage  larva  of  the  dog  nematode  -  toxocara  canis  or  the  cat  nematode  - 
Toxocara  catis.   Human beings  are  infected through ingestion  of  ova  from 
contaminated food or by close contact with puppies.
Histopathology of lesion in Humans: Show granuloma formation around the 
larva & eosinophilic infiltrate.
Clinically human manifestation may take one of 2 forms 
a) Visceral larva Migrans
b) Ocular Larva Migrans
Visceral  Larva  Migrans  (Systemic  Clinical  Features):  is  seen  in  young 
children around 2 years of age with history of PICA. Symptoms include fever, 
nausea, coughing, wheezing, weight loss, hepatomegaly and pruritic eruptions 
over the body.
Ocular Larva Migrans (Ocular Features):  May take 3 forms.
i. Peripheral Granuloma
Presentation: is  usually  during  adolescence  or  adult  life  with  visual 
impairment  from  distortion  of  the  macula  or  retinal  detachment.  In  an 
uncomplicated case lesion may remain undetected throughout life. 
Signs: A white  hemispherical  granuloma may be seen at  or  anterior  to  the 
equator in any quadrant of the fundus. Vitreous bands frequently extend from 
the  lesion  to  the  posterior  fundus.  On  contraction  they  may  give  rise  to 
"dragging" of the disc.
Complications: Macular hetrotropia, tractional retinal detachment 
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ii) Posterior Pole Granuloma
Presentation: is between 6-14 yrs of age with unilateral visual impairment 
Signs:  Absence of uveitis.  A round, yellow-white,  solid granuloma between 
1-2 discs in diameter centred in the juxtrapapillary or subfoveal location.
Complication:  Retinal  stress  lines,  vascular  distortion,  hard  exudates 
surrounding lesion, subretinal hemorrhage and retinal detachment.
iii. Chronic Endophthalmitis
Presentation:  is  between  2-9  years  of  age  with  Leukocoria,  Stratismus  or 
unilateral visual loss.
Signs: Anterior uveitis and vitritis. The peripheral retina and parsplana may be 
covered  by  dense  grayish  white  exudate  similar  to  snow  banking  in  pars 
planitis. 
Complication:  Hypotony, Cataract & tractional retinal detachment.
Differential Diagnosis
1) Retinoblastoma
2) Coat's disease
3) Persistent Hyperplastic Primary vitreous
4) Retinopathy  of  Prematurity,  Familial  Exudative  Vitreoretinopathy, 
Peripheral trauma with peripheral traction.
Investigation
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1. ELISA  titer  of  Anti  toxoplamosis  Antibodies  in  serum,  Aqueous  & 
vitreous.
2. Cytological analysis of Aqueous and vitreous samples for Eosinophils.
3. USG: Highly reflective peripheral mass and vitreous bands.
4. UBM: Pseudocyst at Vitreous base.
TREATMENT
For peripheral Lesion - no treatment required.
For Posterior Pole Lesion:
Dinning and Colleague: 3 Step Approach is recommended which is
Local | Periocular Steriods | Systemic Steroids
+
Antihelminthic Therapy [Thiabendazole adults 800 mg 1 BD x 2 Week]
+
Combine Surgery if appropriate
3. CYSTICERIOSIS
Is caused by cysticercosis cellulosae, the larvae form of pork tapeworm, 
taenia solium. Humans get infected by drinking contaminated water or eating 
food-containing eggs of taenia soluim.
Clinical Features: It may affect any part of the eye from orbit to visual cortex 
but involvement of vitreous cavity  and sub retinal  space are common sites. 
Cyst appears as a translucent mass with a dense white spot at one region with a 
characteristic undulatory movement, which is absent in dead larva.
Rx: Surgical removal of cyst through parsplana route following vitrectomy is 
the treatment of choice.
B. BACTERIAL
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1. TUBERCULOSIS
Intraocular  involvement  by  Mycobacterium  tuberculi  remains 
presumptive  one because  these  bacilli  are  only rarely  isolated from clinical 
specimen. It  is  a relatively rare cause of posterior uveitis,  although recently 
increasing due to AIDS epidemic. The diagnosis of intraocular tuberculosis 
is made if patient fulfils the criteria A with B/C.
A) Clinical suspicion of disease where any 2 of the following features are 
present:
i) Granulomatous anterior uveitis
ii) Active periphlebitis
iii) Neurorentinitis
iv) Retinochoroiditis
v) Subretinal Granuloma/Abscess
B) Corroborative evidence of the disease (any of the 2)
i) Mantoux ≥20mm / Necrosis
ii) Positive X-ray chest
iii) Aqueous /Vitreous tap positive for mycobacterium T.B. by PCR.
iv) Sputum positive for AFB on smear/culture/both
v) Histological  evidence  of  Tuberculosis  from  cervical/parahilar 
lymph node 
C) Response to antituberculous therapy (INH + Rifampicin + Pyrazinamide + 
Ethambutol).
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Posterior Segment Manifestations
i. Disseminated Choroiditis: discrete, yellow, white/gray choroid tubercles, 
0.5-3  mm  in  diameter  associated  with  disc  Edema  and  retinal 
Hemmorhage.
ii) Focal Choroiditis: present as single choroid tubercle about 2-3 DD in size 
with overlying serous Retinal detachment.
Treatment: ATT+ low dose steroids
2) SYPHILIS
Involvement  of  eye  may  occur  by  transmission  of  etiological  agent, 
Treponema pallidum transplacentally (congenital syphilis) or venereally (adult 
syphilis).  Uveal  involvement  is  considered  rare  and  usually  occurs  in  the 
secondary stage of syphilis.
Clinical  Features  : Neuroretinitis  or  choroiditis  (unifocal/multifocal)  with 
varying grade of vitreous inflammation. 
Treatment 
The lesions may resolve spontaneously or by specific treatment using 
penicillin leaving behind hyperpigmentation and mimicing retinitis pigmentosa.
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C. VIRAL
1) HERPES SIMPLEX & HERPES ZOSTER 
Intraocular inflammation may manifest  as either acute retinal necrosis 
or necrotizing herpetic retinopathy.
Acute  Retinal  Necrosis:   is  a  fulminant,  necrotizing  viral  infection  of  the 
retina. Urayama first described it in 1971. ARN occurs in healthy individuals of 
either age/sex. It may be bilateral in 33% of patients.
1) A designation of acute retinal necrosis should be made solely on clinical 
appearance and cause of infection. Clinical characteristic that must be 
seen include:
a) One or more focus of retinal necrosis with discrete borders located in the 
peripheral retina (primarily involving the area adjacent to or outside of 
the major temporal vascular arcades)
b) Rapid  progression  of  disease  (advancement  of  lesion  borders  or 
development of new foci of necrosis) if antiviral therapy has not been 
given.
c) Circumferential spread of disease.
d) Evidence of occlusive vasculopathy with arteriolar involvement 
e) A prominent inflammatory reaction in the vitreous and anterior chamber.
2) Characteristic that support diagnosis include
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a) Optic neuropathy/Atrophy
b) Scleritis
c) Pain
Complications:  Rhegmatogenous Retinal Detachment (50- 75%)
Optic Atrophy
Investigations: ELISA (HSV, HZV, CMV) of Aqueous & Vitreous fluid 
PCR for (HSV, HZV, CMV)
Treatment: Intravenous Acyclovir 150 mg/m2/day in 3 divided  doses X 10-14 
days  followed  by  oral  Acyclovir  500  mg  P.O.  Prophylactic  laser 
photocoagulation may prevent retinal detachment.
2) CMV RETINITIS
CMV  is  one  of  the  Herpes  virus  and  typically  acquired  during 
childhood. After primary infection virus becomes latent and resides in various 
tissues  including  leukocytes,  salivary  and  lacrimal  glands,  periodic  virus 
shedding occurs in blood, urine, respiratory tract. Clinical infection with CMV 
is a late manifestation of HIV infection and CMV retinopathy is seen virtually 
exclusively in patients with a CD4 T cell count of fewer than 100 cells/mm3. 
Upto 40% of patients with CD4 T cells count lesser than 50 cells/mm3 will 
develop CMV Retinitis.
C/F: Lesions consist of areas of creamy, yellowish white, full thickness retinal 
opacification  with  a  variable  amount  of  retinal  hemorrhage  .  CMV lesions 
typically are large and often multiple and tend to follow the vascular supply of 
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the retina. The retinal vessels are abnormal in involved areas and show varying 
degrees  of  narrowing,  occlusion  and  sheathing.Untreated  there  is  always 
relentless  slow progression  of  the  disease  until  the  retina  is  destroyed  and 
vision is lost. Risk of Retinal Detachment has been estimated to be up to 50%
Pathology: Full thickness retinal necrosis with loss of all retinal architecture 
so that healthy retina is replaced by a glial membrane which is applied to RPE.
Diagnosis: Serology  being  of  limited  value  due  to  prevalence  of 
seropositively  in  large  segment  of  population  and  also  because  of 
immunosuppression.
Treatment
1st Choice: Ganciclovir
2nd Choice: Foscarnet.
Ganciclovir I.V
- Treatment dose 5mg / kg IV BD x 14 -21 days
Maintenance dose 6mg / kg OD x 5 days / week
- Administer by slow IV (over 1 hour in 100ml of 0.9% N saline)
- Monitor - complete Hemogram, LFT, Renal, and Electrolytes, Fundus 
examined during treatment.
Intravitreal therapy 
6 injections over 2-3 weeks
Gancicolvir - 100 micro g - 200 micro g / 0.1ml
Foscarnet - 20 micro g  / 0.1ml.
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Intravitreal devices
- GIOD / Vitarest / Chiron Inc.
- Are the longest acting local form of therapy
-   Dimensions of GIOD = Length 5-6mm
Width 4mm
Height 3.5mm
- Composition - 4.5mg of Gancicolvir coated on all sides except one by 
ethylene vinyl acetate.
- Duration of delivery = 5.8 months
- Inserted via parsplana with pellet facing the lens.
- Newer  Agents  -  Cidofovir,  Lobucavir,  An  antisense  oligonucleotide 
(1515-2922), Anti CMV monoclonal Antibody MSL - 109.
3) HIV  Associated  Retinopathy:  Posterior  uveitis  is  most  commonly 
infective in origin and is usually caused by CMV infection. Other causes 
include: -
i) Toxoplasmic  retinochoroiditis:  -  is  common  in  advanced  HIV 
infection and usually is a newly acquired infection. Approximately 50% 
of  HIV  patients  have  coexistent  CNS  disease  and  should  undergo 
neuroimaging. Toxoplasmic retinitis may appear quite atypical in HIV 
infection.   
ii) Mycobacterial  choroiditis:  TB  associated   HIV  is  common  in 
developing  countries.  T.B.  uveitis  is  rare  and  usually  characteristic 
multifocal choroiditis is seen.
iii) Pneumocystis choroidopathy: Single / multiple circumscribed yellow 
sub retinal lesions upto 2DD, which may slowly enlarge is seen.
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D. FUNGAL
1. PRESUMED OCULAR HISTOPLASMOSIS SYNDROME  
Is cause by fungus, histoplasma capsulatum  that is endemic in certain 
regions of world like Missippi valley. Distinct feature is atrophic ‘histo’ spots; 
peripapillary atrophy, linear choroid atrophy and choroidal neovascularisation. 
Earliest symptom is metamorphopsia 
Treatment:- FFA  assisted Laser photocoagulation of CNVM.
2. CANDIDIASIS
It is a normal commensal which spreads hematogenously when immune 
system  is  compromised.  Clinically  lesions  are  multifocal,  discrete,  yellow 
white in early stages, they appears  cottonball or string of pearls in vitreous. 
Rx: Early recognition and antifungal drugs like flucytosine with ketoconazole. 
COMMON  NON  INFECTIONS  ETIOLOGIES  OF  POSTERIOR 
UVEITIS
A) Serpiginous  choroidopathy  -  (Geogrophic  Helicoid  Peripapillary 
Choroidopathy)
This disorder gets its name from the ‘snake’ like pattern of spreading 
inflammation  involving  the  choriocapillaries  and retina.  The  disease  affects 
both  sexes  between  the  ages  of  40  and  60  years.  Though  involvement  is 
bilateral the lesions are always asymmetrical. The exact etiology of disease is 
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unknown but recently association with tuberculosis & Herpes infection have 
been reported.
Clinical features: Symptoms - Blurred version, metamorphopsia,  central and 
paracentral scotomas.
Signs:-  Gray  yellow discoid  lesions  deep  to  the  retina  involving  RPE and 
choriocapillaries at the juxtra papillary, peripapillary region which progresses 
centrifugally in an irregular serpentine fashion with overlying edematous retina 
and vitreous haze. The underlying large choroidal vessels become prominently 
visible  and  there  may  be  mild  degree  of  pigmentary  clumping  also. 
Recurrences occur as creamy infiltration at  the edges of previous scas.  The 
disease  commonly  involves  the  macula  “Macular  GHPC”  and  has  poor 
prognosis.
In chronic and recurrent cases - CNVM, Serous retinal detachment and areas 
of chorioretinal atrophy with subretinal fibrosis is seen.
INVESTIGATION
FFA : - Active Stage:  Early Hypoflourescence with late Hyperflourescence.
Inactive stage: Mottled Hyperflourescence with late staining of scar.
ICGA: Active lesions Early Hyperflourescence with late staining.
Visual field: Absolute / Relative scotoma.
Treatment: 
• The beneficial effect of medical treatment is controversial.
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• However steroid and immunosuppressive is usually recommended.
• CNVM develop in 20% cases, which require laser photocoagulation. 
B. SARCOIDOSIS
Is a multisystem disease that involves lung function primarily. Etiology 
is unknown. Pathologically the characteristic lesion is noncaseating granuloma. 
It usually presents in the 3rd decade (acute presentation or Heerfordt’s disease) 
or  insidiously  in  5th  decade  (Lofgren's  syndrome),  it  is  also  described  in 
children more frequently.
Systemic Features are Ocular Features are
• Pulmonary lymphadenopathy • Acute  /  chronic  nongranulomatous 
uveitis
• Erythema nodosum • Vitreous snow balls
• Hepatomegaly / Spleenomegaly • Vitreous snow balls
• Parotid enlargement • Retinal  periphlebitis  (Candle-wax 
dripping)
• Cardiomyopathy • Retinal, Choroidal Granulomas
• Arthopathy • Preretinal  (Lander’s  sign), 
Parapapillary  &  Optic  Nerve 
Granulomas
• Papillidema
• Peripheral retinal neovascularisation
Investigation: Two most valuable tests are S.ACE and Chest X-Ray whenever 
this disease is suspected. Hypercalciuria is not an infrequent finding. Kveim 
antigen skin testing is positive in 85-90% of cases.
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Treatment: Steroids are the mainstay of treatment; prolonged steroid therapy 
is however often poorly tolerated necessitating steroid sparing options such as 
low dose methotrexate.
C. Vogt-Koyanagi-Harada (VKH) Syndrome
Also known as uveomeningeal syndrome, is a multisystem disorder of 
unknown, possibly immune etiology, which occurs usually in patients between 
the  third  and  fifth  decade.  It  occurs  most  commonly  amongst  the  Asians, 
particularly  Japanese  and  has  a  HLA  predisposition  (HLA-DR4  &  HLA 
DW15).
The disease normally progresses through a) uveitic b) convalescent c) 
chronic recurrent phases.
Ocular inflammation generally preceeds the integumentary changes but 
may also occur concurrently.
VKH Systemic Features
1. Cutaneous Alopecia/perilimbal vitiligo (Sugiura sign)
2. Neurological: meningeal irritation/cranial nerve palsies / convulsions
3. Auditory: (temporary 30%) - vertigo/tinnitis/deafness.
4. CSF pleocytosis.
VKH : Ocular features
1. Anterior uveitis  - B/L granulomatous
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2. Posterior uveitis - occurs in Harada's disease and proceeds as follows:-
i) Optic disc edema and multifocal detachments of the sensory retina with 
small folds radiating from the macular area.
ii) Coalescence of multifocal detachment, resulting in exudative RD
iv) Numerous residual small, mottled, atrophic scars known as `sunset glow' 
fundus develops about 4 weeks after uveitis.
FFA: is  an  important  diagnostic  tool;  shows  early  pin  point 
hyperfluorescent spots at the level of RPE which gradually enlarge as dye pools 
in sub retinal space
Treatment:  Aimed  at  shortening  duration  of  disease  and  preventing 
chronicity, and its complications. Early and aggressive use of systemic steroids 
followed  by  slow tapering  over  3-6  months.  Steroid  resistant  patients  may 
require cyclosporin, azathioprine or chlorambucil.
D) BEHCET'S DISEASE
• is  a  systemic  obliterative  vasculitis  of  unknown cause,  most  commonly, 
seen in Mediterranean countries , middle east and far east eg. Japan.
• The  disease  affects  young  adults  between  20-40  years  of  age  more 
commonly  men than women.  It  has  been strongly  associated with  HLA 
B51.
International diagnostic criteria  - Oral + any 2 of remaining 4
1. Oral: Minor/major apthae ulcers; recurrent atleast 3 times / 1Year.
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2. Genital: recurrent genital apthae/scarring.
3. Eye: Anterior/Posterior uveitis; retinal vasculitis.
4. Skin: Erythema nodosum like lesions.
5. Pathergy: Positive pathergy test read by physician after 24-48 hours.
Ocular features
Anterior uveitis: Severe iridocyclitis with recurrent hypopyon.
Posterior  uveitis: Acute  Stage  -  vitritis,  retinal  vasculitis  involving  both 
arteries  and  veins,  retinal  hemorrhages,  exudates,  focal  retinal  infiltrates, 
papillits.
Chronic stage: Retinal ischemia giving rise to NVD and NVE, Neovascular 
glauoma, optic atrophy.
Treatment
1. Cytotoxic  agents  (Chlorambucil,  Azathioprine,  cyclosporine  and 
cyclophosphamide) 
2. Cortiosteroids
E) Acute Posterior Multifocal placoid pigment epitheliopathy (APMPPE)
Primary  affection  of  retinal  pigment  epithelium  of  unknown  cause, 
affects both sexes in 2-3rd decade with B/L involvement in most cases and is 
often preceded by flu like illness. The inflammation is confined largely to the 
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posterior  pole  and  always  within  the  equator.  The  lesions  are  initially 
multifocal but become confluent later.
IFA : Hypofluorescence in early stage and staining in later stages
Treatment: Natural course with patients regaining good vision.
F) Masquerade Syndromes
Group of disorders that occur with intraocular inflammation and often are 
misdiagnosed  as  chronic  idiopathic  uveitis.  Because  many  of  masquerade 
syndromes are malignant processes, early diagnosis and prompt treatment are 
crucial.
Eg. Malignant disorders: Intraocular lymphoma, leukemia, metastasis to eye 
uveal melanoma, retinoblastoma, xanthogranuloma
Non-malignant disorders: IOFB, retinal detatchment, myopic degeneration.
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AIM OF THE STUDY
To evaluate the various etiologies of posterior uveitis and evaluate the 
effectiveness of treatment.
Introduction
v) Posterior  uveitis  is  a  diagnostic  challenge  "not  only  to  general 
ophthalmologist but also to a uvea specialist" due to varied etiologies 
with their atypical manifestations and lack of specific diagnostic tests.
vi) We tried to find the various prevailing etiologies of this disease in our 
set up and to estimate the effectiveness of treatment by conducting a 
clinical study.
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MATERIALS AND METHODS
The  study  design  was  a  prospective  case  study  of  70  patients  who 
presented  to  Uvea  clinic  at  Regional  Institute  Of  Ophthalmology;  G.O.H. 
during October 2004 - August 2005, for a period of 10 months.
Inclusion Criteria
vii) All patients of posterior uveitis who were first diagnosed in our clinic 
and not treated elsewhere.
Exclusion Criteria
viii) Post traumatic and post surgical uveitis cases.
ix) Anterior, intermediate and panuveitis cases.
x) Patients partially treated else where.
xi) Patients where follow up was less than 1 month.
xii) Patients with infective endophthalmitis, Eale's disease and lens induced 
uveitis.
All these patients were promptly questioned for present complaints, a 
detailed history is taken regarding the duration, onset, severity of attacks and 
previous such attacks. 
Detailed systemic examination was done and  if any abnormality was 
noted,  concerned  specialist  opinion  was  sought  and  involved  in  proper 
management of case.
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Thereafter visual acuity was recorded by Snellen eye chart. A detailed 
Slit lamp biomicroscopy with +90D/+78D/Hruby lens was carried out in most 
of  our  patients.  Vitreous  haze  and  cells  were  graded  by  retro  illumination 
technique as described by kimura and colleagues. 
Indirect ophthalmoscopy with scleral depression was done to rule out 
peripheral  retinal  involvement  in  most  of  our  cases.  The  results  were  well 
documented by appropriate fundus drawings.
So  on  the  basis  of  history  and  examination,  the  following  naming  - 
meshing system described by Nussenblatt et.al. was adopted.
1. Is the disease acute/chronic
2. Is the inflammation granulomatous/nongranulomatous
3. Is the disease unilateral/bilateral
4. What are the demographics of the patient
5. What are the associated symptoms and signs patient have
And  after  sorting  out  the  list  of  probable  causes  in  each  group  the 
differential diagnosis is generated for the each  case. Based on this differential 
diagnosis the relevant investigation was ordered to confirm/refute the clinical 
suspicion.  Other  departments  like  retina  clinic  opinion  were  also  sought  to 
generate more clinical acumen regarding the disease.
We  adopted  a  step  up  approach  for  various  investigations  ordered  to 
necessitate  our diagnosis.  This approach was mainly self  tailored according to the 
diagnostic value of the test, sensitivity, specificity of the test, its cost effectiveness, its 
availability and whether the test will make any difference to the treatment of patient 
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as described  by Nozik et.al. Our investigation approach for various common diseases 
suspected in our study group is shown below.
Suspected 
Disease 1st Choice Test
2nd Choice 
Test
3rd Choice test
(if required)
1. Toxoplasmosis Indirect fluorescent antibody titer →
Elisa antibody 
titer →
PCR of vitreous 
sample
2. Toxocariasis Indirect fluorescent antibody titer →
Elisa antibody 
titer, B-Scan →
PCR, Eosinophil 
of Vitreous/
Acqeous Sample
3. Serpiginous choroidopathy FFA → ICGA
4. CMV retivitis Elisa HIV CD4/CD8 count →
FFA urine and 
serum culture 
(in paediatric)
5. Tuberculosis Montoux, chest x-ray, ESR, Sputum, AFB →
PCR T.B.  of 
Serum →
PCR T.B. of 
Vitreous 
6.
Collagen 
Vascular 
Disease
Rf., ANA, ANCA →
Serum Anti 
DNA Abs.
Anti 
Phospholipid 
Antibodies.
7. Vogt Koyanagi Harada FFA → HLA typing →
lumbar puncture 
in acute stages 
for pleocytosis
8. Acute Retinal necrosis FFA
9. Sarcoidosis CXR, serum ACE Serum/A/G ratio →
HRCT Chest 
scan 
conjunctival 
biopsy
10. APMPPE FFA → ICG
Investigation Protocol
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Patients were treated as per the guidelines (discussed before) given for 
each specific disease though cost constraints/drug availability did prevent us 
from adopting the first line of choice of treatment in some cases. 
All our patients were advised to strictly adhere to the treatment protocol 
and  follow  up  visits.  Non-compliance  to  drugs  either  due  to  patient 
socioeconomic factors or side effects were sought in each follow up visits.
At each follow up visit, the patient visual acuity was assessed, asked for 
symptoms  complex,  detailed  ocular  examination  was  done,  and  following 
which patients was advised to adjust the dosage of drugs. During our follow up 
we tried to grade the category of our treatment response in categories like;
Status quo / worsening / improving / recurrence / steroid-dependency / 
immunosuppressant requirement / surgical procedure required.
Our approach to various diseases were: -
1. Idiopathic
This large group of cases where etiology was unknown was usually treated 
with  periocular  steroids  and  systemic  steroids  as  we  have  ruled  out  most  of  the 
infective etiologies. This group of patients was more closely and regularly followed 
up as we were not aware of the cause in these cases.
2. Infective & Non Infective Etiologies and our choice of treatment 
We tried  to  strictly  follow the  duration  of  treatment  for  the  specific 
infective etiologies though our tailored choice was as follows:-
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Disease 1st Choice Drug 2nd Choice Drug
1. Toxoplasmosis T.Cotriamazole (DS) → T.Azithromycin
2. Toxocariasis Steroids → Thiabendazole
3. Serpiginous 
choroidopathy
Corticosteroids 
(systemic)
→ Immuno suppressant Azathiopnine
4. CMV retinitis HAART  with  reference  to  other  institute  for  IV  ganciclovir/ 
implants. 
5. Tuberculosis ATT with low dose steroids
6. Collagen Vasc. 
Disease
Corticosteroids → I.V. Cyclophosphamide pulse
7. VKH High dose of systemic 
corticosteroids and I.V. 
methyl prednisaline
→ Immunosuppressants
8. Acute  Retinal 
necrosis
I.V. Acyclovir followed by oral Acyclovir
9. Sarcoidosis Corticosteroids with referral to internal  medicine department  for 
complete treatment
10. APMPPE Follow up of patient alone
Treatment Protocol
After  this  analysis  of  our  observations  were  made  using  various 
statistical tools like mean, average, standard deviation and probability charting, 
t - test and null hypothesis were used whenever required. 
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ANALYSIS AND OBSERVATION
1. Number of patients enrolled in our study = 102
Patients lost during follow up period =  32
Final number of patients available for analysis= 70
Range of Follow up period                               =   1-11 months 
Mean average of follow up period               =       2.3 months/ 
 individual
2. Age Incidence
Year Group No. of Patients Percentage
0-10 Years 4 6%
10-20 Years 5 7%
20-30 Years 8 11%
30-40 Years 20 30%
40-50 Years 15 21%
50-60 Years 8 11%
> 60 Years 10 14%
Mean Age Incidence  was 37.8 years ± 10.1 years (2S.D) in our study. 
The higher incidence of uveitis in 3rd-4th decade was also seen in other major studies. 
Also we noticed toxocariasis cases commoner in younger age group and Serpiginous 
choroidopathy cases commoner in elderly patients.
3. Sex Incidence
No. of Patients Percentage
Male 38 54%
Female 32 46%
Males out numbered females in our study.  Mean age of onset in males 
was  36.7  years.  Mean  age  of  onset  in  females  was  38.8  years.  Males 
preponderance was noted in previous other studies also
4. Laterality
No. of Patients Percentage
RE 19 27%
LE 17 24%
Both eyes 34 48%
Bilateral involvement was commoner than unilateral involvement and 
no eye has a predominant predilection.
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5. Course of disease
No. of Patients Percentage
Acute 18 26%
Chronic 37 53%
Recurrent 15 21%
26% of our patients have acute course i.e. inflammatory response lasting 
<  3  months.  53%  of  our  patients  have  chronic  course  of  disease  i.e. 
inflammatory response lasted for longer than 3 months.  21% have recurrent 
uveitis i.e. 3 or more episodes of intraocular inflammation.
6. Presenting Complaints
No .of Patients Percentage
Floaters 16 23%
Diminished vision 30 43%
Pain 5 7%
Photophobia 8 11%
Redness 5 7%
Watering 5 7%
White Eye Reflex 1 2%
Diminished  vision  (43%)  and  floaters  (23%)  were  the  commonest 
complaints in our patients. These being the most common symptoms reported 
in posterior uveitis in other major studies as well.
Prominent Medical History
No.of Patients Percentage
Diabetes 8 11%
Hypertension 8 11%
Tuberculosis 4 6%
AIDS 3 4.5%
Cancer 1 1.5%
Arthritis 4 6%
Collagen Vascular disease 2 3%
We found close association of CMV Retinitis patients with AIDS.
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Prominent Medical Symptoms
No.of Patients
Fever 10
Weightloss 4
Hair Loss 3
White skin patch 2
Rash/Intertrigo 6
Nodules 1
Skin sores 5
Photosensitivity 2
Painful Joint 4
Swollen joint 2
Low back pain 2
Stiff joint 1
Mouth ulcer 1
Dental caries 14
Dental gingivitis 8
Difficulty in breathing 3
Headache 2
Hoarseness 4
Ear discharge 2
Vaginal discharge 3
Vaginal itching 3
7. Dietary History
No.of Patients Percentage
Veg 28 40%
Non Veg 42 60%
8. Personal History
No. of Patients
Owned pets 
Close contact with dog/puppy/cat
3
8
Treated water usage
Untreated water usage
18
52
Unprotected sexual intercourse 4
Pregnancy 3
Drug Allergies 4
We found uncooked meat, untreated water usage and close contact with 
pets were associated with toxoplasmosis and toxocariasis cases.
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9. Systemic Associates
No.of Patients Percentage
Skin 16 22%
Dental 22 31%
ENT 6 8.5%
Rheumatology 9 12%
Gynecology 7 10%
Internal medicine 7 10%
Dental foci were common association in patients with idiopathic posterior 
uveitis. Null hypothesis was applied and results were statistically significant (p 
<  0.1).  Skin  foci  were  also  commonly  associated  was  also  statistically 
significant (p < 0.05).
10. Type of Choroiditis
Pattern No.of Patients Percentage
Focal 5 11%
Multifocal 31 67%
Diffuse 10 22%
67%  our  patients  had  multifocal  choroiditis  type  of  anatomical 
involvement. This was also seen in other major studies.
11. Etiological Diagnosis
No.of Patients Percentage
Idiopathic 30 42.8%
Infective 27 38%
Non Infective 13 18%
43% of our cases were idipathic ie. The intraocular inflammation could 
not be attributed to a specific ocular cause. The remaining 57% were due to 
infective or non-infective etiologies.
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Clinical Diagnosis
No.of Patients %
Idiopathic 30 42.8%
Toxoplasmosis retinochoroidits 12 17.1%
Toxocariasis retinochoroidits 8 11.4%
Serpiginious choridopathy 8 11.4%
CMV retinitis 4 5.7%
Tuberculosis retinochoroiditis 2 2.8%
Collagen Vascular disease retinitis 2 2.8%
Vogt Koyanagi Harada syndrome 1 1.4%
Acute retinal necrosis 1 1.4%
Acute posterior multifocal placoid 
pigments Epitheliopathy 
1 1.4%
Sarcoidosis 1 1.4%
Toxoplasmosis (42.8%), Toxocariasis (17.1%), Serpiginous choroidopathy 
(11.4%) & CMV retinitis (11.4%) accounted for major number of cases in our 
study. The comparison with other studies is drawn in discussion.
12. Immunofluorescent Antibody assay of TORCH Titers
Type of antibody No.of patients with positive titers %
1. IgG Toxoplasmosis
IgM Toxoplasmosis
20
12
28%
17%
2. IgG Toxocariasis
IgM Toxocariasis
6
6
8.5%
8.5%
3. IgG Rubella
IgM Rubella
9
5
13%
7%
4. IgG Cytomegalovirus
IgM Cytomegalovirus
24
13
34%
18%
5. IgG Herpes simplex Virus I
IgM Herpes simplex virus II
5
5
7%
7%
6. IgG Herpes Simplex Virus II
IgM Herpes Simplex virus II
6
5
8.5%
7%
7. IgG Treponema pallidum
IgM Treponema pallidum
5
3
7%
4%
Significant number of clinical suspicious cases of toxoplasmosis showed 
IgM positive titers and high IgG titers. CMV positivity rates were high in our 
case series (34%) although not associated with disease in majority of cases.
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13. FFA findings
Findings No. of Patients %
Papillitis 11 16%
Vasculitis 16 23%
CNVM 6 8.5%
Cystoid macular edema 16 23%
Active choroiditis 12 17%
Old Scar staining 22 32%
Staining of Scar tissue (32%) vasculitis (23%), Cystoid Macular Edema 
(17%) were commonest findings in FFA study.
14. Treatment Groups - Medical 
Type of Treatment No.of Patients %
Systemic steroids 46 40%
Periocular steroids 24 21%
Topical steroids 20 17%
Immunosuppresants 7 6%
Specific therapy against infections 18 16%
Majority  of  our  cases  were  started  on  combination  of  systemic  and 
Periocular steriods (61%) only few were treated with immunosuppresants (6%)
15. Change in Vision % on Snellen after steroid use
Snellen chart No.of Patients %
Increase in > = 2 Lines 17 25%
No change 46 65%
Decrease > = 2 lines 7 10%
We found improvement in 25% of our cases and no worsening in 66% of 
patients on mean of 3 months of steroid usage.
16. Steroid Responsiveness
No.of Patients %
Steroid responders 36 65%
Steroid non responders 8 14.5%
Recurrence on steroids 5 9%
Steroid dependence 6 10%
68
17. Response to Specific Therapy
Response Antitoxo plasmosis
Anti 
toxocariasis
Anti 
CMV Anti viral
Anti 
tuberculosis
Improving 7 2 1 0 2
Worsening 2 1 1 1 1
Status quo 3 5 2 1 1
58%  of  toxoplasmosis  patients,  50%  of  tuberculosis  patients,  25%  of 
toxocariasis  and  25%  of  CMV  Retinitis  patients  showed  improvement  to 
specific therapy against the infection.
18. No. of patients requiring immunosuppressants
No. of Patients %
Methotrexate 2 3%
Azathioprine 3 4%
Cyclophosphamide 2 3%
We used immunosuppressants in 7 of our patients - mostly for Serpiginous 
choroidopathy and steroid - non responders and recurrence on steroids group of 
patients.
19. Intraocular Surgery Required in
Type of Surgery No. of Patients %
Cataract 13 18%
Vitrectomy 6 8.5%
Filtering 6 8.5%
20. Final Visual Acuity in treatment group
Visual Acuity > 6/9 % 6/12-6/36 % <6/60 %
Before Treatment 17 24 21 30 12 17
After Treatment 25 35 17 24 10 14
24% of Patients with visual acuity >6/9, increased to 35% and 17% of 
patients with visual acuity <6/60 decrease to 14%. Both signified improvement 
in visual acuity after treatment.
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DISCUSSION
Differential Diagnosis of Posterior Uveitis is extensive with the pattern of 
uveitis keep changing with time and with the emergence of new uveitic entities. 
Various genetic, ethnic, demographic and environmental factors also influence 
the patterns. Our study results were compared with 4 recent major studies to 
compare any such change in patterns
1. Biswas et al. "Pattern of uveitis in a referred uveitis clinic in South India" 
International Ophthalmology Journal 1996-1997; 20: 223-28.
3. Rodriguez  et.al.  "Pattern  of  uveitis  in  a  tertiary  Eye  care  centre" 
Archives Ophthalmology 1996; 114" 593-599.
3. Biswas et al. "Changing Patterns of uveitis in a referral uveitic clinic in 
India" AIOS proceedings 2000.
4. Ramandeep Singh et.al. "Patterns of uveitis in a referral Eye clinic in 
North India" IJO June 2004; 52; 121-125.
POSTERIOR UVEITIS ETIOLOGIES
Disease 
Etiology
Our 
Study
Biwas 
et.al. 1996
Rodriguez 
et al. 1996
Biswas 
et.al. 2000
Ramandeep 
et.al. 2004
Idiopathic 42.8% 40.9% 13.3% 5.25% 24.7%
Toxoplasmosis 17.1% 27.8% 24.6% 9.83% 8.0%
Serpiginous 11.4% 18.8% 1.6% 35.26% 25.1%
Toxocariasis 11.4% 5.8% 2.5% 4.05% 2.5%
CMV Retinitis 5.7% 0.55% 11.6% 6.25% 1.21%
Tuberculosis 
Retinochoroiditis
2.8% 2.16% 0.6% 1.32% 8.9%
Collagen 
Vascular Disease 
Retinitis
2.8% 5.0% 7.9% 5.0% 3.0%
Acute Retinal 
Necrosis
1.4% 0.82% 5.5% 1.73% 3.2%
APMPPE 1.4% 1.37% 2.0% 2.31% 1.6%
VKH 1.4% 8.0% 5.0% 6.25% 16%
Sarcoidosis 1.4% 5.0% 7.5% 4.25% 0.8%
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The various inferences drawn are 
1) Idiopathic cases (42.8%) accounted for the largest group in our series of 
patients. This was comparable to initial study by Biswas et.al. 1996 - 
(40.9%).  But  it  was  significantly  higher  comparing  to  studies  by 
Ramandeep et al.  2004. The reason accounting would be due to non-
availability of certain expensive tests under our purview like PCR for 
T.B, chorioretinal biopsy etc.
2) Toxoplasmosis (17.1%) cases were the leading cause of Posterior  uveitis 
in  our  group  which  tallied  with  other  studies  of  Biswas  et.al.  1996, 
Rodriguez et.al. 1996. However the percentage of cases were lower than 
that  reported  by  Holland  and  Engstrom  (30%  -  50%).  Notingly 
Ramandeep  et  al.  2004  in  the  recent  study  reported  only  8.0%  of 
posterior uveitis cases as toxoplamosis and Biswas et.al. 2004 reported 
only 9.85% and felt that reason for decrease in referral was that many of 
the  cases  were  congenital  and  usually  healed.  Although  we  reported 
high incidence were of Toxoplosmosis which were active.
3) Serpiginous  choroidopathy  being  the  2nd  major  cause   (114%)  in  our 
study confirms the high prevalence of this disease in Indian subcontinent 
as evidence by the previous Indian studies - Biswas et.al. 1996 (18.8%), 
Biswas et.al. 2000 (35.26%) and Ramandeep (25.1%) in comparison to 
Rodriguez study 1996 at Boston (1.6%). But incidence in our study was 
not as high as reported by Ramandeep et.al. and Biswas et al. Neither we 
found any significant correlation between tuberculosis and Serpiginous 
Choroiditis as reported by Ramandeep et al.
4) We reported significantly higher number of cases of toxocariasis in our 
study (11.4%) equaling the number of cases of Serpiginous choroiditis 
and much higher than previous studies reported in India. The reasons 
being  largely  unknown but  majority  of  our  cases  were  children  and 
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significant history and PICA/association with pets were noted in these 
cases.  This  represent  a  changing  trend  in  the  current  scenario  of 
etiologies of posterior uveitis.
5) CMV Retinitis  cases  were  also substantial  (5.7%) comparable  with the 
earlier studies of Rodriguez et al. 1996 (11.6%). All these cases were 
positive for HIV ELISA signifying the commonest retinal lesion in HIV 
patients being CMV retinitis. Also signifying the increasing incidence of 
HIV patients in Indian subcontinent.
6) Tuberculosis  retinochoroiditis  (2.8%)  casaes  were  less  reported  in  our 
study group comparing with Ramandeep et.al. (8.9%) the reasons being 
the use of PCR for mycobacterium tuberculi on vitreous sample by the 
author; so the hidden cases were detected. We acknowledge our inability 
to  pick  up  these  hidden  cases.  Prevalence  of  Tuberculosis 
retinochoroiditis could be higher as shown in the above study.
7) We  reported  only  Systemic  Lupus  Erythromatosus  as  a  cause  in  our 
collagen vascular disease retinitis (2.8%) group. This was significantly 
lower than reported by Rodriguez et.al. 1996 (7.9%).
8) Other cases like Acute retinal necrosis, Acute posterior multifocal placoid 
pigment Epitheliopathy, VKH Syndrome accounted for few other cases. 
These new disease entities  are increasingly detected due to increased 
awareness among ophthalmologists.
Our Study also analysed the effectiveness of various specific treatment 
modalities in our patients with different etiologies, Results were comparable 
with previous studies like- 
1) Effectiveness  of  treating  ocular  toxoplasmosis  by  a  course  of  TMP-
Sulphamethoxazole (TMP = 5 mg/Kg,  sulphamethoxaxole 25 mg/Kg) 
for period of 1 month with concomitant use of systemic steroids. We 
reported dramatic healing in 7 out of 12 cases with decrease in sign & 
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symptoms. The results were comparable with Torre et.al. Randomized 
trial of TMP-Salphamethoxazole versus Pyri-sulphadiazine for therapy 
of  toxoplasmosis,  Antimicrobial  agents  chemotherapy  1995,  42: 
1346-1349.
2) We  reported  marginal  improvement  in  patient  with  pregnancy  with 
macular  choroiditis   due  to  Toxoplasmosis  on  treatment  with 
T.Spiramycin comparable with previous study by Wing S, Remington: 
Toxoplasmosis  in  pregnancy  Clinical  Infectious  Disease  1994,  18:  
853-62.
3) Treatment trial  with immunosuppressants  was beneficial  in Serpiginous 
choroiditis  cases,  which  showed  significant  response  by  preventing 
disease  activity  and  macular  involvement.  This  was  comparable  to 
Biswas et.al. - Immunosuppressants role in Serpiginous choroidopathy 
in the "changing patterns of uveitis in tertiary care centre".
4) Response to Thiabendazole therapy in our patients with active toxocariasis 
lesion when given concomitant with steroids was not very substantial. 
We need to do further treatment trials to come to any firm conclusion 
regarding its benefits.
5) Response  to  CMV   Retinitis  patients  to  IV.Ganciclovir  and  HAART 
Therapy and ATT for Tuberculous Retinochoroiditis was mixed. 50% 
patients in each group improved after therapy or remained status quo. 
6) Both  of  our  patients  with  SLE  Retinitis  went  for  consequetive  optic 
Atrophy inspite of being treated with pulses of Cyclophosphamide and 
steroids.  Patient  with  Acute  Retinal  Necrosis  didn't  show  much 
improvement  in  final  visual  acuity  even  after  IV  acyclovir  and  oral 
acyclovir treatment.
7) Patients with VKH syndrome and sarcoidosis showed good response to 
systemic immunosuppressant therapy.
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8) Finally we assessed the response of Idiopathic and non infectious posterior 
uveitis cases to systemic and periocular steroids and found 25% of case 
showed increase in  ≥ 2 lines of visual  acuty  on Snellens chart on 3 
months  follow  up  with  no  worsening  in  65%  of  cases.  This  was 
significant statistically (p < 0.1) and results were comparable with other 
major studies. 
9) We found 10% steroid dependence rates with 15% of patients were steroid 
non-responders 9% of patients showed recurrence on steroids. In these 
groups addition of 2nd line immunosuppressants allowed reducing the 
dose of systemic prednisolone as well in controlling inflammation and 
reducing the number of relapses to a significant extend comparable with 
study  on  clinical  outcome  of  chronic  immunosuppression  in  non 
infectious  uveitis  by  "Victor  et.al.  Clinical  &  Experimental 
ophthalmology 2005; 33:16-21. 
10) Also  the  efficacy  of  posterior  subtenon  was  similar  to  orbital  floor 
injections in our study group.
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SUMMARY
1) The most common age group is 31-40 years in our study with mean follow 
up period of 2.3 months / individual.
2) Male  preponderance was  noted with  both eyes  involvement  commonly 
seen.
3) Most of patients had chronic course of disease.
4) Most common symptoms were floaters and diminished vision.
5) Significant association was seen in patients with untreated water usage, 
uncooked  meat  and  closed  contact  with  pets  with  diseases  like 
Toxoplasmosis & Toxocariasis.
6) Dental & Skin foci of infection has a common association with Idiopathic 
posterior uveitis cases.
7) Anatomically multifocal choroiditis was the commonest pattern.
8) TORCH  Immunofluorescent  Antibody  assay  gives  good  corroborative 
evidence  of  disease  based  on  clinical  suspicion  although  the  sero 
conversion is more significant than a single high reading.
9) CMV Seropositivity rates were high in our population and don't warrant 
any active treatment in the absence of lesion.
10)Toxoplasmosis,  Toxocariasis,  Serpiginous  Choroidopathy  and  CMV 
Retinitis associated with HIV infection were the major etiological causes 
identified in our series of patients.
11)Response to specific therapy to toxoplasmosis was good. 
12)Serpiginous  Choriodopathy  patients  showed  good  response  to 
immunosuppressants.
13)Response to steroids is noninfective idiopathic cases was substantial.
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 CONCLUSION
Posterior uveitis remains a diagnostic challenge to the ophthalmologist. 
By knowing the present changing trends and geographical patterns help him to 
err on the approach of "Common things are more common and to be considered 
in Diagnosis first". Also it helps him to focus on new emerging uveitic entities.
We were able to achieve a good discretion of some common causes of 
posterior uveitis like Toxoplasmosis, Toxocariasis and Serpiginous choroiditis 
and  recommended  the  importance  of  detailed  clinical  history  and  clinical 
examination.
The recent drugs available against them were found to be really effective 
except toxocoriasis treatment.
The investigations have to be undertaken with clear  objectives and not 
irrationally to avoid unnecessary expenditure for the patients.  We found the 
effectiveness of TORCH titers in providing corroborative evidence of diseases 
in cases of posterior uveitis.
76
PROFORMA FOR POSTERIOR UVEITIS
M.R.No.
Government Eye Hospital Uvea No.
Egmore, Chennai Date
I. Name Occupation Age/Sex Address
Occupation Community
2. Present History
RE LE Duration Onset Severity Course
Pair Acute/Insi Mild/Mod/Sev. Acute/Chronic/Rec.
Redness Acute/Insi Mild/Mod/Sev. Acute/Chronic/Rec.
Photophobia Acute/Insi Mild/Mod/Sev. Acute/Chronic/Rec.
Floaters Acute/Insi Mild/Mod/Sev. Acute/Chronic/Rec.
Defective vision Acute/Insi Mild/Mod/Sev. Acute/Chronic/Rec.
Any other specific complaints
H/O previous attack :- Treated/Not treated
II. General Medical History and review - fever/night sweats/weight loss
1. Systemic illness :Diabetes, Hypertension, tuberculosis, cancer, 
AIDS, Arthritis, collagen vascular disease, fever
2. Skin :Vitiligo, alopecia, poliosis, rash, nodules, sores, 
Sunburn Easily.
3. Joints :Painful or swollen joints, low back pain, stiff joints.
4. GIT :Painful mouth ulcers, stomach ulcers, bloody 
stools.
5. Dental :Caries, gingivitis, pain in teeth, tooth loss, recent 
surgery.
6. Pulmonary :Cough more than 3 months, hemoptysis, difficulty 
in breathing.
7. ENT :Frequent sneezing, sinus trouble, hoarseness, ear 
Discharge, tinnitis
8. GUT :Genital ulcers, penile discharge
9. Gynec :Vaginal discharge, itching
III. Past  h/o:  -  D.M./HTN/T.B./Herpes/Shingles/Any  sexually  transmitted 
disease / Eye / General Surgeries.
IV. Family history : T.B./Arthritis/diabetes/cancer
V. Personal History Contact with dog/cat/puppies/sick animals
h/o of pica (especially in children)
Vegetarian - Raw Uncooked sausage
Non-vegetarian Uncooked meat
       Pork/Beef/Steak
Water - Untreated water/treated water
H/o unprotected sexual exposure
Pregnant/near future plan
VI. History of drug allergy - Esp. sulpha group, Penicillin
VII. Summary of History - Acute/chronic
- Unilateral/bilateral
- Demographic details
Age  <15 yrs - Toxocariasis  Sex female - JRA
Age 15-45 yrs. - Toxoplasmosis, ARN, AIDS, VKH  Male- AS, Sympathetic
Age > 45 yrs - Serpiginous, Birdshot
Any Striking detail
VIII.  General Examination
   Anemia/Lymphadenopathy
IX. Skin :
Dental :
ENT :
Rheumatology :
Gynecology :
CVS :
RS :
GIT :
CNS :
X. Ocular Examination
RE LE
i. Vision
ii. Conjunctiva
iii. Cornea
iv. AC Flare Grade
Cells grade
Hypopyon
v. Iris
vi. Pupil
vii. Lens
viii. Vitreous
Flare Grade
Cells Grade
Debris
Strands
Hemorrhage
Miscellaneous
ix. Retina
Disc
Vessel
Macula
Posterior pole
Periphery
Miscellaneous
x. Choroid
Choroiditis Location - Location -
Focal Granuloma Number - Number -
Multifocal Appearance - Appearance -
Diffuse/geographic
Serous retinal Detachment
Hard exudates
Old Scars
Pigmentation
CNVM
Miscellaneous
RE LE
xi. Fundus
xii. Laboratory test Results
1. Blood Hemoglobin
Total Count
Differential count
ESR
CRP
CD4+/CD8+
Culture
2. Urine Routine
Culture
3. Serum ANA
ANCA
Rf
Anti DNA Abs.
ACE
Ca+
A/G Ratio
Lysozyme
VDRL
TPHA
4. Immunofluroscent Antibody assay IgM IgG
Toxoplasmosis
Toxocariasis
Rubella
CMV
Herpes Simplex Type I
Herpes Simplex Type II
Treponemal
5. Elisa HIV Results
Western Blot HIV
RE LE
6. Radiological
Chest X-ray
Skill X-ray (lateral view)
CT/MRI Brain
HRCT Chest
7. Skin Test
Mantoux
Pathergy
Kveim
Anergy
8. HLA typing
HLA B-27
HLA B-5
HLA A-29
& MT3/HLA BW 22J
9. Fundus fluorescein angiography
10. Indocyanine green angiography
11. Ultrasonography
12. Skin/Gland/Hair Biopsy
13. Aqueous/Vitreous Sample
Cytology
Staining
Culture
PCR
14. Chorioretinal Biopsy
15. Specialists Opinion
Skin
Dental
ENT
Rheumatology
Gynecology
Paediatric
Chest & T.B.
Neurology
Internal medicine
Diabetology
Hypertensive Clinic
RE LE
xiii. Clinical Diagnosis Infective/noninfective/i
diopathic
Infective/noninfective/id
iopathic
xiv. Differential diagnosis On  basis  of  history  /age  /  sex  /  demographic  / 
lateralilty  /  onset  /  granulomatous  /  nong. 
Appearance/Tests
xv. Treatment
Medical
- Corticosteroid (Topical)
 (Periocular)
(Systemic)
- Specific Therapy
- Immunosuppressants
- Any other medications
Surgery  -  Cataract  /vit.  / 
Glaucoma
xvi. Followup visits & Plan
Date
Visual 
acuty  and 
response
Date
Visual 
acuty and 
response
Status quo (•)
Worsening (↓)
Improving (↑)
Recurrence (*)
Steroid Dependency (  )
Surgery planned (x)
Addition of immuno 
suppressants (+)
xvii Final comments
KEYS TO MASTER CHART
P = Pain VS = Vitreous Strands
R = Redness VHAEM = Vitreous Hemorrhage
PH = Photophobia IPVD = Incomplete posterior 
vitreous detachment
F = Floaters CPVD  =  Complete  posterior 
vitreous detachment
DV = Diminished Vision DE = Disc Edema
DY = Days DH = Disc Hyperemia
MO = Months OA = Optic Atrophy
YRS = Years VA = Vessel Attenuation
COUR: Course of Disease VO = Vessel Obliteration
AC = Acute VASC = Vasculitis
CHR = Chronic VASS = Vascular Sheathing
REC = Recurrent CME = Cystoid macular edema
LAT = Laterally MH = Macular Hole
OD = Right type MP = macular pigmentation
OS = Left eye TRD = Tractional Retinal 
detachment
OU = Both Eyes ERD =Exudative Retinal 
detachment
DM = Diabetes Mellitus RRD = Rhegmatogenous retinal 
detachment
HTM = Hypertension RE = Retinal edema
TB = Tuberculosis RH = Retinal hemorrhage
GP = GIT Problem HEX = Hard Exudates
RP = Respiratory Problem SEX = Soft Exudates
JP = Joint Problem ERM = Epiretinal membrane
DF = Dental Foci MCM = Multifocal chroidal mass
EF = ENT Foci DCM = focal choroidal mass
SF = Skin Foci MACC = Macular choroiditis
GF = Gynec.foci OLDC = Old Choroiditis Scar
V = Vegetarian POL  = Punched out lesions
NV = Non vegetarian ACE = Angiotension converting 
enzyme
PR - Pregnant TREP = Treponema pallidium
UPS = Unprotected sexual intercourse Toxop = Toxoplasmosis  
Sys/SpecEx-Systemic & specialty 
examination
Toxoc = Toxocariasis canis
CCC = Circumcomeal congestion RUB = Rubella
KP = Keratic Precipitates CMV = Cytomegalo virus
FL = Flare in Anterior Chamber HSVI = Herpes Simplex Virus I
CE = Cells in Anterior Chamber HSVII = Herpes Simplex Virus II
HY = Hypopyon CXR = Chest X-ray
PS = Posterior Synechia SXR = Skull X-ray
PSC = Posterior subcapsular cataract HRCT = High resolution CT Scan
VH = Vitreous flare LN = Lymph nodes
VC = Vitreous cells CAL = Calcification
VD = Vitreous debris SIN = Sinusitis
CM =  Cardiomegaly HAART \ HIV Anti retroviral 
therapy
MX = Montoux SX = Surgery
EHP  = Early hypofluorescence CAT = Cataract Surgery
LHY = Late Hyper fluorescence VIT = Vitrectomy
LEAK = Leakage FIL = Filtering surgery
CNVM = Choroidal neovascular 
membrane
↓ = Worsening
DS = Disc Staining ↑ = Improving
LMS = Margins of Lesion Staining • = Status Quo
TOXOPRC = Toxoplasmosis 
retinochoroditis
* = Recurrence
TOXOCRC = Toxocariasis 
retinochoroiditis
  = Steroid Dependence
SERPC = Serpiginous choroidopathy += Addition of immunosuppressants
CMVR = CMV Retinitis
CVDRC = Collagen vascular disease
TUBRC = Tuberculosis 
retinochoroiditis
VKH = Vogt Koyanagi Harada 
Syndrome
ARN = Acute Retinal Necrosis
APMPPE = Acute Posterior Placoid 
Pigment Epitheliopathy 
SARC = Saroidosis
ST = Topical steroids
SP = Periocular steroids
SS = Systemic steroids
I = Immuno suppressant
MTX = Methotrexate
AZT = Azathioprine
CP = Cyclophosphamide
ACY = Acyclovir
ATT = Anti Tuberculosis therapy
SPF = Sulpha + Pyri + FA
SEP = Septran
THIA = Thiabendazole
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